HER2 POSITIVE BREAST CARCINOMA
Clinical trials for HER2 POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HER2 POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HER2 POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial halted early: targeted combo tested for tough breast cancer
Disease control TerminatedThis study aimed to see if adding a new drug called copanlisib to standard treatments could better control advanced HER2-positive breast cancer in people with specific genetic changes. It was designed to first find a safe dose and then test if the three-drug combination could kee…
Matched conditions: HER2 POSITIVE BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Trial aims to tame harsh chemo gut side effects
Symptom relief TerminatedThis study tested whether the antibiotic rifaximin could reduce severe stomach pain, diarrhea, and other gut problems caused by a standard breast cancer drug combination. It involved 20 women with early-stage HER2-positive breast cancer who were experiencing these side effects. T…
Matched conditions: HER2 POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC